Author:
Sahi Jasminder,Smith Cornelia,Easterwood LaHoma,Grepper Susan,LeCluyse Edward
Reference188 articles.
1. Can the pharmaceutical industry reduce attrition rates?;Kola;Nat Rev Drug Discov,2004
2. USFDA Draft Guidance for Industry: Drug Interaction Studies- Study Design, Data Analysis, and Implications for Dosing and Labeling Recommendations 2012
3. Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies;Hewitt;Drug Metab Rev,2007
4. Expression and induction of a large set of drug-metabolizing enzymes by the highly differentiated human hepatoma cell line BC2;Gomez-Lechon;Eur J Biochem,2001
5. Regulation of cell morphology and cytochrome P450 expression in human hepatocytes by extracellular matrix and cell-cell interactions;Hamilton;Cell Tissue Res,2001